Real-World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Longitudinal Analysis of Hydroxychloroquine Blood Level Monitoring and Its Effects on Lupus Outcomes: Findings from a Prospective Cohort Study

  • By

  • Jay J. Patel

  • Fauzia Hollangel

  • Caroline Packee

  • Amita Kapoor

  • Brad Rovin

  • Nathalie Costedoat-Chalumeau

  • Shivani Garg

  • May 3, 2026

Share

Original Source(s)

Real-World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

  • by Jay J. Patel, Fauzia Hollangel, Caroline Packee, Amita Kapoor, Brad Rovin, Nathalie Costedoat-Chalumeau, Shivani Garg

  • May 3, 2026

Related Content

Can an antibody aid neuropsychiatric SLE diagnosis?

Investigators compared a candidate biomarker across three diagnostic groups.

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.

The mirror of illness: identity, embodiment, and clinical care in systemic sclerosis